Aptamer Details

HER-2 (HB5) (ID# 380)

HER-2 (HB5)
DNA HER2 peptide Protein 18.9 nM (reported value) Hanks buffer with 0.1 mg/mL salmon sperm DNA and 1 mg/mL of BSA 37°C NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding. Targets HER2-expressing cell lines such as SK-BR-3.
Does not bind to HER2-negative cell lines MDA-MB-231 and MCF-7.
Aptamer was complexed with doxorubicin and selectively delivered doxorubicin to HER2-positive cells in vitro.
5' dApdApdCpdCpdGpdCpdCpdCpdApdAp dApdTpdCpdCpdCpdTpdApdApdGpdAp dGpdTpdCpdTpdGpdCpdApdCpdTpdTp dGpdTpdCpdApdTpdTpdTpdTpdGpdTp dApdTpdApdTpdGpdTpdApdTpdTpdTp dGpdGpdTpdTpdTpdTpdTpdGpdGpdCp dTpdCpdTpdCpdApdCpdApdGpdApdCp dApdCpdApdCpdTpdApdCpdApdCpdAp dCpdGpdCpdApdCpdAp3' 89 26271.12 g/mole 811300 L/(mole·cm) 43.02% 1.23 32.38

Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.

Z Liu et al. Novel HER2 aptamer selectively delivers cytotoxic drug to HER2-positive breast cancer cells in vitro. J Transl Med 10(2012): 148-157.

Have your aptamer oligo synthesized ORDER NOW

Community Feedback